EMA Recommends Dozens Of Suspensions Over Flawed Synchron Studies
Generic Marketing Authorizations To Be Suspended Following Similar Criticism From US FDA
The EMA’s CHMP has recommended the suspension of marketing authorizations for around 100 generics after identifying “irregularities” in how bioequivalence studies were conducted by Synchron Research Services.
